BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15266874)

  • 1. Intratympanic steroid perfusion for the treatment of Ménière's disease: a retrospective study.
    Dodson KM; Woodson E; Sismanis A
    Ear Nose Throat J; 2004 Jun; 83(6):394-8. PubMed ID: 15266874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transtympanic steroids for Ménière's disease.
    Herraiz C; Plaza G; Aparicio JM; Gallego I; Marcos S; Ruiz C
    Otol Neurotol; 2010 Jan; 31(1):162-7. PubMed ID: 19924013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease.
    She W; Lv L; Du X; Li H; Dai Y; Lu L; Ma X; Chen F
    J Laryngol Otol; 2015 Mar; 129(3):232-7. PubMed ID: 25655232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
    Shea PF; Richey PA; Wan JY; Stevens SR
    Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic steroid injections for intractable Ménière's disease.
    Barrs DM; Keyser JS; Stallworth C; McElveen JT
    Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
    Gabra N; Saliba I
    Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of quality of life after intratympanic streptomycin injection in patients with Ménière's disease.
    Jung J; Chun J; Kim N; Kim Y; Lee WS
    Otol Neurotol; 2008 Sep; 29(6):816-23. PubMed ID: 18617871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of intratympanic methylprednisolone perfusion for intractable Meniere's disease].
    Lu L; Dai Y; She W; Yu C; Chen F; Wang J; Ma X; Qin X; Gao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov; 24(22):1012-5. PubMed ID: 21322924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
    Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
    Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.